Przemysław Sobczak

Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study

Jacek Kubica, Piotr Adamski, Katarzyna Buszko et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2019 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study

Piotr Adamski, Joanna Sikora, Ewa Laskowska et al. · PLoS ONE · 2017 · 29 citations · Full text

Medicine, Cardiology, Pharmacology +17

Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest

Julia M. Umińska, Jakub Ratajczak, Katarzyna Buszko et al. · Cardiology Journal · 2019 · 24 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The differential role of uric acid – The purpose or cause of cardiovascular diseases?

Emilia Siemińska, Przemysław Sobczak, Natalia Skibińska et al. · Medical Hypotheses · 2020 · 19 citations

Life Sciences, Cardiology, Physiology +9

Mild therapeutic hypothermia for patients with acute coronary syndrome and cardiac arrest treated with percutaneous coronary intervention (UNICORN). The design and rationale for the prospective, observational, multicenter study

Julia Maria Kubica, Krzysztof Pstrągowski, Piotr Adamski et al. · Medical Research Journal · 2016 · 11 citations · Full text

Medicine, Cardiology, Internal Medicine +13